Information Library
Results for: Business transformation - Capital
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
UK Market Access Insight Brief
White Paper — May 30, 2012
Insight Briefing series on Market Access in key European countries -
Partnering to Maximize Rewards in Pharmerging Markets
White Paper — September 15, 2011
In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending. -
Quintiles Supports Samsung's Entry into BioPharma Market through Joint Venture
Press Release — February 28, 2011 – The Samsung Group, South Korea’s largest industrial group, has entered into a strategic partnership with Quintiles, to support Samsung’s entry into the bio pharmaceuticals market.
-
The New Health Alliance
White Paper — January 10, 2011
Biopharmaceutical companies must explore alternative strategic alliances that meet the needs of the New Health and produce medicines that demonstrate value to the entire constellation of stakeholders. -
Challenging Traditional Outsourcing Models Using Core And Non-Core Assessment
Presentation — June 30, 2010
-
QUINTILES AND MOVETIS ANNOUNCE STRATEGIC ALLIANCE
Press Release — January 28, 2010 - Quintiles announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.
-
QUINTILES’ SUCCESS IN MANAGING STRATEGIC ALLIANCES PROFILED IN HARVARD BUSINESS REVIEW
Press Release — January 11, 2010 - “Managing Alliances with the Balanced Scorecard” details how Solvay Pharmaceuticals and Quintiles managed their innovative development alliance to deliver value for both companies.
-
Managing Alliances with the Balanced Scorecard
Video — January 11, 2010
One particularly well done aspect of the Solvay-Quintiles alliance was its use of multiple committees and teams to keep the alliance on track and deliver -
Managing Alliances with the Balanced Scorecard
Video — January 11, 2010
Robert S. Kaplan, Baker Foundation Professor at Harvard Business School, explains why corporate alliances often fail, and how Solvay Pharmaceuticals and Quintiles achieved success through -
Managing Alliances with the Balanced Scorecard
Case Study — January 11, 2010
“Managing Alliances with the Balanced Scorecard” details how Solvay Pharmaceuticals and Quintiles managed their innovative development alliance to deliver value for both companies.
